phenobarbital sodium msds - An Overview
phenobarbital sodium msds - An Overview
Blog Article
pentobarbital will lessen the level or effect of amlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
Contraindicated (1)pentobarbital will reduce the level or effect of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the development and elimination of cariprazine's active metabolites.
Contraindicated (1)pentobarbital will lower the level or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is really a delicate CYP3A4 substrate. Coadministration with potent or average CYP3A4 inducers is contraindicated.
pentobarbital will lower the extent or effect of tramadol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Reduced AUC of tramadol as well as the Lively metabolite (O-desmethyltramadol) when coadministered with solid CYP3A4 and CYP2B6 inducers
Monitor Intently (one)pentobarbital will lessen the extent or effect of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or effect of pantoprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar.
pentobarbital will minimize the level or effect of fentanyl intranasal read more by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Coadministration of fentanyl with CYP3A4 inducers may lead to the decrease in fentanyl plasma concentrations, deficiency of efficacy or, maybe, advancement of the withdrawal syndrome in a very individual that has formulated physical dependence to fentanyl.
Check Carefully (1)pentobarbital will reduce the level or effect of cannabidiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or effect of vincristine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.
pentobarbital will decrease the level or effect of ambrisentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.
pentobarbital will decrease the extent or effect of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
The effect from the resultant lessened blood levels of griseofulvin on therapeutic reaction hasn't been proven. On the other hand, It will be preferable to stop concomitant administration of such drugs.
pentobarbital will reduce the extent or effect of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
Acute or Persistent pain: Warning ought to be exercised when barbiturates are administered to clients with acute or Persistent pain, for the reason that paradoxical pleasure can be induced or critical symptoms could be masked.